24/7
Buzz
Startups
VC
AI
DefenseTech
Opinions
Events
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Corporate
Appointments
Tech Gateways
HR - The Next Leap
Ctech Testimonials
Projects
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Rimsa
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
DefenseTech
OPINIONS
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
12:34
Tel Aviv Stock Exchange posts surge in revenue and profit as market activity accelerates
12:18
Israel quietly receives INS Drakon as its newest submarine expands the navy’s strategic reach
11:25
El Al turns wartime disruption into record demand and $132 million quarterly profit
11:13
OpenAI and Anthropic incidents put Israeli AI security startup Irregular at center of race to safely test AI agents
More stories
Buzz
Most popular
Daily
Weekly
1
Billionaire Beny Steinmetz challenges $1.4 million tax demand over $9 million Israeli home sale
2
Salesforce veterans raise $20 million pre-Seed from Marc Benioff and Michael Dell to tackle AI’s enterprise bottleneck
3
Wix's Base44 bet comes at a price as losses widen to $76.4 million
4
Monday seeks to double CEO pay weeks after announcing 620 layoffs
5
25-year-old AI investor’s $16 billion bet hits a brutal reality check
More news
Rimsa
3 stories about Rimsa
Israeli court documents reveal worrying details on Teva’s decision to acquire Mexico’s Rimsa
08.06.20
|
Sophie Shulman
Classified documents show that Teva's board of directors didn't even dedicate a full meeting to the acquisition
Derivative Suit Sheds Light on Teva’s Disastrous Rimsa Acquisition
28.05.19
|
Hezi Sternlicht
Teva acquired Mexican drugmaker Rimsa in 2016, but an anonymous email sent a week after the deal’s completion led Teva to launch an internal investigation—and sue the sellers for fraud
Teva and Rimsa Settle Contested $2.3-Billion Acquisition Deal Out of Court
10.04.18
|
Dror Reich
Teva acquired the Mexican plant in 2016 but shut it down immediately, citing discrepancies between Rimsa's regulatory filing and the actual assets, and filed a suit against the former owners